Isabel Aznarez co-discovered Stoke Therapeutics’ TANGO technology (Targeted Augmentation of Nuclear Gene Output), which uses a novel approach to treating the underlying cause of severe genetic diseases. Six thousand five hundred genes may be amenable to TANGO.
.